What is 5-Amino-1MQ, and is it a peptide?
5-Amino-1MQ is 5-amino-1-methylquinolinium, a small-molecule inhibitor of the enzyme nicotinamide N-methyltransferase, or NNMT [1]. Despite the common search 5 amino 1mq peptide, it is not a peptide; it has no amino-acid chain. PinPoint's library lists it as primarily preclinical, logged by mouth once daily, with no package or capsule example [3].
The paired GLP-1 searches ask a different question from the compound itself: whether two things can be recorded together and kept apart. This guide answers the evidence question from the two animal papers in the library and the record-keeping question from what the app does. It does not combine the two into a plan, because no source studied them together.
What do the 5-Amino-1MQ studies report?
NNMT methylates nicotinamide and is expressed at higher levels in fat and muscle in some metabolic conditions [1]. A 2018 study tested a series of methylquinolinium NNMT inhibitors: in cultured fat cells they lowered the reaction product 1-methylnicotinamide, raised intracellular NAD+ and suppressed fat synthesis [2].
In the same paper, diet-induced obese mice given a potent inhibitor from the series lost body weight and adipose mass and showed smaller fat cells while staying on a high-fat diet [2]. The inhibitor was given systemically to mice; the study reports no human data.
A 2021 rat study built an assay for 5-Amino-1MQ and used it after intravenous and oral dosing. It reported a mean terminal half-life of 3.8 hours after intravenous dosing and 6.9 hours after oral dosing, with oral bioavailability of about 38.4% [1]. The library models the oral route with the 6.9 hour rat value and says plainly that no human data are published [3].
| Compound | Status | Half-life input | Package example |
|---|---|---|---|
| 5-Amino-1MQ | Primarily preclinical, estimated model data | 6.9 h | Not listed |
How is 5-Amino-1MQ measured and converted?
An oral entry skips everything that makes injectable arithmetic hard. There is no powder to dissolve, no water volume and no syringe unit, so the conversion is a product: milligrams per capsule times the number of capsules equals the milligrams logged [4]. The library holds no sourced capsule strength, so this page leaves it as a variable instead of inventing a number [3].
Timing arithmetic is where the rat half-life appears. At 6.9 hours per halving, about 9% of a single modeled contribution remains after 24 hours, and about 3.1% after five half-lives, 34.5 hours [4]. The peptide calculator is for powder vials; 5-Amino-1MQ has no compound-specific calculator because there is nothing to reconstitute.
How do people log 5-Amino-1MQ next to a GLP-1 in PinPoint?
PinPoint supports injection, oral, nasal, topical and sublingual routes in one library, so an oral 5-Amino-1MQ entry and a weekly GLP-1 injection such as semaglutide or tirzepatide sit in the same history as separate compounds [5]. Each keeps its own schedule: a daily reminder for one, a weekly reminder for the other, each at the time chosen [5].
The Home curve models each compound from its own half-life input, the rat-derived 6.9 hours here and the labeled values for the GLP-1 [3][5]. Those curves are mathematical visualizations of model inputs, one rat-derived and one labeled, do not account for individual variation, and say nothing about how the two compounds interact [5]. Side effects with severity ratings and daily notes can be recorded alongside both, so anything noticed is attached to a dated entry rather than to memory.
Get PinPoint on the App StoreWhat do people ask about 5-Amino-1MQ?
- Is 5 amino 1mq a peptide?
- No. 5-Amino-1MQ is 5-amino-1-methylquinolinium, a small-molecule NNMT inhibitor. It sits in the same app library as peptides, but it has no amino-acid chain.
- Is there a human 5 amino 1mq dosage?
- No human amount appears in the library's sources. The cited studies dosed rats and mice, and the library labels the entry primarily preclinical.
- What is the half-life of 5-Amino-1MQ?
- In rats, about 6.9 hours after oral dosing and 3.8 hours after intravenous dosing. The library uses the oral rat value for its model and notes that no human data are published.
- Can 5-Amino-1MQ and a GLP-1 be tracked in one app?
- PinPoint records them as separate compounds with separate schedules and curves. The app does not evaluate combinations, and no source in the library studied the two together.
Where do these facts come from?
Sources are listed by kind: labels first, then peer-reviewed papers, then PinPoint's own library, arithmetic and app description. Library values were retrieved from the PinPoint application on 5 October 2026; vendor listings support package sizes only.
- Assay and rat pharmacokinetics of 5-amino-1-methylquinolinium, 2021J Pharm Biomed Anal, 2021. Intravenous and oral dosing in rats.Retrieved 2026-10-05 · study
- NNMT inhibitors in diet-induced obese mice, 2018Biochem Pharmacol, 2018. Methylquinolinium inhibitor series.Retrieved 2026-10-05 · study
- PinPoint compound library, application recordsHalf-life inputs, routes, frequencies, package examples and confidence labels as stored in the iOS app library and mirrored in the peptide guides.Retrieved 2026-10-05 · library
- Unit conversion arithmeticConcentration = amount / volume; volume = amount / concentration; U-100 units = mL x 100; remaining fraction = 2^(-elapsed / half-life).Retrieved 2026-10-05 · arithmetic
- PinPoint App Store descriptionFeature wording from the approved application description, not pricing.Retrieved 2026-10-05 · app-description